LYKALABSPharmaceuticals
Lyka Labs Ltd — Quarterly Results & Earnings
₹44.95
-9.04%
Profit Growth YoY-260.00%Latest quarter
Sales Growth YoY-10.93%Latest quarter
Sales CAGR 5Y17.63%5 year compound
Profit CAGR 5Y17.89%5 year compound
📋
Quarterly Performance
YoY Profit Growth-260.00%
🔴 Significant decline
YoY Sales Growth-10.93%
🔴 Significant decline
OPM 5Y Average
27.50%Operating profit margin
EPS Growth 5Y
17.32%Interest Coverage
2.31Higher = safer debt servicing
ROE
9.31%ROCE
9.91%💡
Growth Analysis
Lyka Labs Ltd reported YoY profit growth of -260.00% and revenue growth of -10.93% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 17.63% and profits at 17.89% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Lyka Labs Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.